Search Page

1

Cite

Share

Alternative and Experimental Therapies of Mycobacterium abscessus Infections.

Meir M, Barkan D. Meir M, et al. Among authors: barkan d. Int J Mol Sci. 2020 Sep 16;21(18):6793. doi: 10.3390/ijms21186793. Int J Mol Sci. 2020. PMID: 32948001 Free PMC article. Review.

Cite

Share

2

Cite

Share

NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models.

Moquin SA, Simon O, Karuna R, Lakshminarayana SB, Yokokawa F, Wang F, Saravanan C, Zhang J, Day CW, Chan K, Wang QY, Lu S, Dong H, Wan KF, Lim SP, Liu W, Seh CC, Chen YL, Xu H, Barkan DT, Kounde CS, Sim WLS, Wang G, Yeo HQ, Zou B, Chan WL, Ding M, Song JG, Li M, Osborne C, Blasco F, Sarko C, Beer D, Bonamy GMC, Sasseville VG, Shi PY, Diagana TT, Yeung BKS, Gu F. Moquin SA, et al. Among authors: barkan dt. Sci Transl Med. 2021 Feb 3;13(579):eabb2181. doi: 10.1126/scitranslmed.abb2181. Sci Transl Med. 2021. PMID: 33536278

Cite

Share

3

Cite

Share

Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis.

Watson A, Li H, Ma B, Weiss R, Bendayan D, Abramovitz L, Ben-Shalom N, Mor M, Pinko E, Bar Oz M, Wang Z, Du F, Lu Y, Rybniker J, Dahan R, Huang H, Barkan D, Xiang Y, Javid B, Freund NT. Watson A, et al. Among authors: barkan d. Nat Commun. 2021 Jan 27;12(1):602. doi: 10.1038/s41467-021-20930-0. Nat Commun. 2021. PMID: 33504803 Free PMC article.

Cite

Share

4

Cite

Share

The QcrB Inhibitors TB47 and Telacebec Do Not Potentiate the Activity of Clofazimine in Mycobacterium abscessus.

Sorayah R, Moraski GC, Barkan D, Pethe K. Sorayah R, et al. Among authors: barkan d. Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0096421. doi: 10.1128/AAC.00964-21. Epub 2021 Sep 20. Antimicrob Agents Chemother. 2021. PMID: 34543090 Free PMC article.

Cite

Share

5

Cite

Share

EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?

Weidenfeld K, Barkan D. Weidenfeld K, et al. Among authors: barkan d. Front Oncol. 2018 Sep 12;8:381. doi: 10.3389/fonc.2018.00381. eCollection 2018. Front Oncol. 2018. PMID: 30258818 Free PMC article. Review.

Cite

Share

6

Cite

Share

Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities.

Hen O, Barkan D. Hen O, et al. Among authors: barkan d. Semin Cancer Biol. 2020 Feb;60:157-165. doi: 10.1016/j.semcancer.2019.09.002. Epub 2019 Sep 3. Semin Cancer Biol. 2020. PMID: 31491559 Review.

Cite

Share

7

Cite

Share

Assessing a Novel 3D Assay System for Drug Screening against OS Metastasis.

Koons N, Amato N, Sauer S, Warshawsky D, Barkan D, Khanna C. Koons N, et al. Among authors: barkan d. Pharmaceuticals (Basel). 2021 Sep 25;14(10):971. doi: 10.3390/ph14100971. Pharmaceuticals (Basel). 2021. PMID: 34681195 Free PMC article.

Cite

Share

8

Cite

Share

Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells.

Sauer S, Reed DR, Ihnat M, Hurst RE, Warshawsky D, Barkan D. Sauer S, et al. Among authors: barkan d. Front Oncol. 2021 Apr 27;11:659963. doi: 10.3389/fonc.2021.659963. eCollection 2021. Front Oncol. 2021. PMID: 33987095 Free PMC article. Review.

Cite

Share

9

Cite

Share

Morphological Characterization of Antibiotic Combinations.

Coram MA, Wang L, Godinez WJ, Barkan DT, Armstrong Z, Ando DM, Feng BY. Coram MA, et al. Among authors: barkan dt. ACS Infect Dis. 2022 Jan 14;8(1):66-77. doi: 10.1021/acsinfecdis.1c00312. Epub 2021 Dec 22. ACS Infect Dis. 2022. PMID: 34937332

Cite

Share

10

Cite

Share

β1-integrin: a potential therapeutic target in the battle against cancer recurrence.

Barkan D, Chambers AF. Barkan D, et al. Clin Cancer Res. 2011 Dec 1;17(23):7219-23. doi: 10.1158/1078-0432.CCR-11-0642. Epub 2011 Sep 7. Clin Cancer Res. 2011. PMID: 21900388 Review.

Cite

Share